Development of the Angelman syndrome video assessment: quantifying meaningful change

The ASVA was developed with insights from the AS community, including caregivers of individuals with AS, clinicians, and researchers. The ASVA is a novel, disease-specific, clinician-reported outcome measure that uses standardized video capture and scorecards that were developed through a rigorous process, resulting in well-developed criteria to quantify meaningful changes of function in individuals with AS in communication, ADLs, gross motor function, and external direction.

Authors

Institutions

Publication Details

Journal
Journal of Neurodevelopmental Disorders
Published
2025-11-03
DOI
https://doi.org/10.1186/s11689-025-09655-z
Citations
1
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of the Angelman syndrome video assessment: quantifying meaningful change

Kriszha A. Sheehy, Anjali Sadhwani, Ashley A. Sapp, Lynne M. Bird et al.
1 citations
Journal of Neurodevelopmental Disorders
Genetic Syndromes and Imprinting
1.82
article

Development of the Angelman syndrome video assessment: quantifying meaningful change

Kriszha A. Sheehy, Anjali Sadhwani, Ashley A. Sapp, Lynne M. Bird, Maria A. Fragala-Pinkham, Claudia Senesac, Caroline Woeber, B Black, Lauren DeValk, Olivia Boorom, Robert W. Komorowski, S. Benítez Rivero, Nicole Harris, Wen‐Hann Tan, Rebecca Woods, Amanda Guevara, Jessica Duis, Rhys Huw Thomas, Nancy C. Brady, Marie Thomas, Cody M. Washburn, Kara Arps, Jessica Lopes, Anne Wheeler, Rebecca Crean, Catherine B. McClellan, Christina K. Zigler, Jennifer Jones, Curtis A. Hanson, R. Leonard, Mindy Leffler, Kristen K. Madison, Michelle Ozick, Kelsey Pauley, Courtney Swafford
article en
1 citations

Abstract

The ASVA was developed with insights from the AS community, including caregivers of individuals with AS, clinicians, and researchers. The ASVA is a novel, disease-specific, clinician-reported outcome measure that uses standardized video capture and scorecards that were developed through a rigorous process, resulting in well-developed criteria to quantify meaningful changes of function in individuals with AS in communication, ADLs, gross motor function, and external direction.

Journal of Neurodevelopmental DisordersVol. 17(1)
Boston Children's Hospital (US), University of Kansas (US), University of Pittsburgh (US), Ionis Pharmaceuticals (United States) (US), Plymouth Marine Laboratory (GB), Children's Hospital Colorado (US), Seva Mandir (IN), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US)
Ionis Pharmaceuticals
Openalex Percentile: Top 11%
Genetic Syndromes and Imprinting
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.